Detalles de la búsqueda
1.
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
J Hepatol
; 78(2): 281-292, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36208843
2.
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial.
Clin Gastroenterol Hepatol
; 20(12): 2800-2808, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864158
3.
Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for genotype 6 chronic hepatitis C.
J Formos Med Assoc
; 121(11): 2265-2272, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35581112
4.
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis.
Cancer Immunol Immunother
; 70(7): 1929-1937, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33409737
5.
Persistent augmentation of central arterial stiffness following viral clearance by direct-acting antivirals in chronic hepatitis C.
J Viral Hepat
; 28(1): 159-167, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32929802
6.
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).
J Gastroenterol Hepatol
; 36(10): 2884-2892, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33963615
7.
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan.
J Gastroenterol Hepatol
; 36(8): 2247-2254, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33624849
8.
Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan.
J Formos Med Assoc
; 120(3): 983-990, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32891488
9.
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy.
J Infect Dis
; 222(8): 1345-1352, 2020 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32396638
10.
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
Am J Gastroenterol
; 115(8): 1226-1235, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32221162
11.
Real-world effectiveness and safety of ledipasvir/sofosbuvir for genotype 6 chronic hepatitis C patients in Taiwan.
J Gastroenterol Hepatol
; 35(3): 467-472, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31445507
12.
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis.
J Gastroenterol Hepatol
; 34(11): 1977-1983, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30931537
13.
Real-world effectiveness and safety of sofosbuvir plus daclatasvir with or without ribavirin for genotype 2 chronic hepatitis C in Taiwan.
J Formos Med Assoc
; 118(5): 907-913, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30316677
14.
Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infection.
Gut
; 67(7): 1342-1350, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28615303
15.
Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation.
Cell Microbiol
; 19(4)2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27665576
16.
HBsAg expression of liver correlates with histological activities and viral replication in chronic hepatitis B.
Ann Hepatol
; 13(6): 771-80, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25332263
17.
Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B.
Aliment Pharmacol Ther
; 59(2): 230-238, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37845815
18.
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
Clin Mol Hepatol
; 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637957
19.
Reversibility of some oxidative stress markers in chronic hepatitis C patients after receiving direct-acting antiviral agents.
J Virus Erad
; 9(1): 100318, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37065432
20.
Chronic Hepatitis C Virus Infection: An Ongoing Challenge in Screening and Treatment.
Life (Basel)
; 13(10)2023 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37895346